PRESS RELEASE
Nov 14, 2023
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
Nov 08, 2023
BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services
Nov 06, 2023
BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
Nov 03, 2023
BioStem Technologies Closes Oversubscribed $2M Private Placement
Oct 24, 2023
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
Oct 20, 2023
PRISM MediaWire – Weekly Press Resume – Oct. 16 to Oct. 20, 2023
Oct 18, 2023
BioStem Technologies to Present at the Fall Foliage MicroCap Rodeo Conference
Oct 17, 2023
BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
Sep 29, 2023
BioStem Technologies: CMS Decision a “Win For Patients”
Sep 26, 2023
BioStem Technologies Takes on Diabetic Foot Ulcers with Innovative Wound Care Product